Friday, Nov 30, 2018
Phil Wilkin: 1957 – 2018: R.I.P.
R.I.P. Philip Wilkin. You gave so much to so many and asked for so little in return. Saying such sad farewells today to our Board Member, Phil Wilkin, who passed away unexpectedly on Saturday, Nov. 24, 2018.
Novel Surrogate End Point Proposed in Hepatocellular Carcinoma
New research on patients with intermediate hepatocellular carcinoma (HCC) who have undergone conventional transarterial chemoembolization (cTACE) suggests that the duration of a response to a treatment, rather than the robustness of the response, may be a better predictor of overall survival. The study was published in JAMA Network Open.